Sara Talpos’s article about peptides in Undark (and also published in Stat News) might be the most t...
There’s good news on the drug-shortages front, according to the latest report from the American Soci...
HHS’s Office of the Inspector General has issued a new advisory bulletin about pharma manufacturers ...
With patents for semaglutide expiring in the not-too-distant future, Novo Nordisk is pulling out all...
According to a ProPublica analysis, “the FDA has lost more than 400 workers who support inspections ...
Welcome, Parenteral Drug Association! Our newest Bronze-level Corporate Patron, PDA is a global prov...
Welcome, Tailor Made Compounding! Our newest Silver-level Corporate Patron, Tailor Made Compounding ...
Number 6 will blow your mind! We just love* the clickbait headline from Everyday Health: “9 Signs Yo...
Running for the board? If you’re thinking about running for the 2025–26 APC Board of Directors, don’...
This week in Compounding Interests. Scott talks about the shortage of bright-line compliance standar...